Omnicell gits $1.2B revenue milestone but misses Q4 earnings targets
Omnicell (NASDAQ:OMCL) reported a record top-line performance for the full year 2025 on Thursday, though shares faced pressure as fourth-quarter earnings fell short of Wall Street's expectations due to higher-than-anticipated operating costs.











